Drug
Henagliflozin clinical trials
Also written SHR3824.
- studies test it
- 27
- open now
- 11
- in phase 3
- 2
- first study started
- 2013
Keep track of what changes. Save the henagliflozin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- SHR3824
- 11
Combined with it in one product
Studies by the year they started
27 studies that test it; most in 2024 (6)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 5 |
| 2017 | 3 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 12
- Phase 2
- 1
- Phase 3
- 2
- Phase 4
- 8
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 13 · Other 14
Jiangsu HengRui Medicine Co., Ltd. (13) · Qian geng (1) · The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (1) · First Affiliated Hospital of Guangxi Medical University (1) · The First Affiliated Hospital of Air Force Medicial University (1) · Shanghai East Hospital (1) · First Affiliated Hospital of Wannan Medical College (1) · Xiqiao Zhou (1)
Often tested with
Tested in the same studies.
Gliclazide (1) · Metformin (1) · Simvastatin (1) · Retagliptin (1)
Studies
Open first, then newest update. How each study uses henagliflozin is read from its arms, and is right about nine times in ten.
Testing it · 27
- Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEFNot yet recruitingPhase 1/2The First Affiliated Hospital of Air Force Medicial UniversityNCT07687212Written as Henggliflozin
- Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMRNot yet recruitingNot applicableShanghai East HospitalNCT07294495Written as Henagliflozin (SGLT2 Inhibitor)
- The Effects of Henagliflozin on Glucose Fluctuation and Immunosenescence in Type 2 Diabetes Patients on Insulin TherapyRecruitingPhase 4Xinhua Hospital, Shanghai Jiao Tong University School of MedicineNCT06818851Written as Henggliflozin
- Effect of Henagliflozin on Renal Outcomes in Non-dialysis Patients With Advanced Chronic Kidney Disease : A Multicenter Prospective, Randomized Controlled Trial（HERO -aCKD）Not yet recruitingPhase 4First Affiliated Hospital of Wannan Medical CollegeNCT07027774Written as Henagliflozin 5 mg Group
- Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DMNot yet recruitingPhase 4Xiqiao ZhouNCT06762223Written as Henagliflozin 10 mg daily
- Henagliflozin's Impact on Prediabetes RemissionNot yet recruitingPhase 4Shandong Provincial HospitalNCT06448130Written as Henagliflozin 5mg
- Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver DiseaseNot yet recruitingPhase 4Sir Run Run Shaw HospitalNCT06218342Written as Henagliflozin
- Efficacy of Henagliflozin for Weight Loss in Obesity Without DiabetesNot yet recruitingPhase 4The First People's Hospital of ChangzhouNCT06216340Written as Henagliflozin
- The Effect of Henagliflozin and Metformin on Myocardial Tissue-level CharacteristicsNot yet recruitingNot applicableRenJi HospitalNCT06059287Written as Henagliflozin
- Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal AxisNot yet recruitingNot applicableQianfoshan HospitalNCT06031389Written as Henagliflozin
- Effect of Henagliflozin on Cardiac Function in Type 2 Diabetes Patients With Chronic Heart Failure (HERO-HF)RecruitingNot applicableSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityNCT05742230Written as Henagliflozin 10 mg
- Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial InfarctionCompletedPhase 4Qian gengNCT06187727Written as Henagliflozin
- Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical TrialCompletedNot applicableThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolNCT06085703Written as Henagliflozin
- Combination of Henagliflozin and Continuous Subcutaneous Insulin Infusion in T2DMCompletedPhase 4First Affiliated Hospital of Guangxi Medical UniversityNCT05677334Written as Henagliflozin
- Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 DiabetesStatus unknownPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT04390295Written as SHR3824
- Drug-drug Interaction Between Simvastatin and SHR3824Status unknownPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT03329118Written as SHR3824, Simvastatin
- Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic ImpairmentStatus unknownPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT03160014Written as SHR3824
- Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal InsufficientStatus unknownPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT03159832Written as SHR3824
- Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 DiabetesStatus unknownPhase 3Jiangsu HengRui Medicine Co., Ltd.NCT03159052Written as SHR3824
- The Drug-drug Interaction of SHR3824 and SP2086Status unknownPhase 1Jiangsu HengRui Medicine Co., Ltd.NCT02500485Written as SHR3824, SP2086
See all 27 studies that test henagliflozin →
As the comparator · 1 — what is tested is compared with henagliflozin
Codes
What other systems call henagliflozin · ClinicalTrials.gg INT000532
- MeSH (NLM) C000611095henagliflozinOne source NLM
- UNII (FDA) 21P2M98388HENAGLIFLOZINConfirmed NLM, Wikidata
- Wikidata Q27253567henagliflozinConfirmed NLM, Wikidata
- DrugBank DB11939One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000611095 | henagliflozin | One source NLM |
| UNII (FDA) | 21P2M98388 | HENAGLIFLOZIN | Confirmed NLM, Wikidata |
| Wikidata | Q27253567 | henagliflozin | Confirmed NLM, Wikidata |
| DrugBank | DB11939 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.